Evidence map›Paper›PMID 35038902›Full record

ArticlemBio2022

A Filamentous Bacteriophage Protein Inhibits Type IV Pili To Prevent Superinfection of Pseudomonas aeruginosa.

Amelia K Schmidt, Alexa D Fitzpatrick, Caleb M Schwartzkopf, Dominick R Faith, Laura K Jennings, Alison Coluccio, Devin J Hunt, Lia A Michaels, Aviv Hargil, Qingquan Chen and 6 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Phages and quorum sensing: findings to consider in phage therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Amelia K SchmidtDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Alexa D FitzpatrickDepartment of Biochemistry, University of Torontogrid.17063.33, Toronto, Ontario, Canada.
Caleb M SchwartzkopfDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Dominick R FaithDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Laura K JenningsDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Alison ColuccioDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Devin J HuntDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Lia A MichaelsDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.
Aviv HargilDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford Universitygrid.168010.e, Stanford, California, USA.
Qingquan ChenDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford Universitygrid.168010.e, Stanford, California, USA.
Paul L BollykyDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford Universitygrid.168010.e, Stanford, California, USA.
David W DorwardResearch Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Jenny WachterLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Patricia A RosaLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Karen L MaxwellDepartment of Biochemistry, University of Torontogrid.17063.33, Toronto, Ontario, Canada.
Patrick R SecorDivision of Biological Sciences, University of Montanagrid.253613.0, Missoula, Montana, USA.ORCID 0000-0001-7123-3037
University of Montana · USNational Institutes of Health · USStanford University · USUniversity of Toronto · CA

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
Molecular Genetic Basis of the Infectious Cycle of Borrelia burgdorferiZIAAI000917 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ROSA, PATRICIA A · 2009 to 2023
$13.7M
Immunization against filamentous bacteriophages to prevent bacterial infectionR01AI138981 · NIAID · UNIVERSITY OF MONTANA · PI EVANS, JAY T. · 2018 to 2022
$5.4M
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis lung InfectionsR01HL148184 · NHLBI · STANFORD UNIVERSITY · PI MILLA, CARLOS · 2019 to 2022
$1.7M
Studies on bacteriophages in respiratory diseasesK24AI166718 · NIAID · STANFORD UNIVERSITY · PI Paul L Bollyky · 2022 to 2026
$815k
CIHR PJT-165936NHLBI NIH HHS R01 HL148184NIAID NIH HHS K24 AI166718NIAID NIH HHS R01 AI138981NIGMS NIH HHS P20 GM103546
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that causes infections in a variety of settings. Many P. aeruginosa isolates are infected by filamentous Pf bacteriophage integrated into the bacterial chromosome as a prophage. Pf virions can be produced without lysing P. aeruginosa. However, cell lysis can occur during superinfection, which occurs when Pf virions successfully infect a host lysogenized by a Pf prophage. Temperate phages typically encode superinfection exclusion mechanisms to prevent host lysis by virions of the same or similar species. In this study, we sought to elucidate the superinfection exclusion mechanism of Pf phage. Initially, we observed that P. aeruginosa that survive Pf superinfection are transiently resistant to Pf-induced plaquing and are deficient in twitching motility, which is mediated by type IV pili (T4P). Pf utilize T4P as a cell surface receptor, suggesting that T4P are suppressed in bacteria that survive superinfection. We tested the hypothesis that a Pf-encoded protein suppresses T4P to mediate superinfection exclusion by expressing Pf proteins in P. aeruginosa and measuring plaquing and twitching motility. We found that the Pf protein PA0721, which we termed

Indexed as

InovirusSuperinfectionBacterial ProteinsFimbriae, BacterialHumansPseudomonas aeruginosaBacterial Proteinsfilamentous bacteriophagePf4PilCPseudomonas aeruginosasuperinfection exclusiontwitching motilitytype IV pili

Identifiers

PMID35038902
PMCPMC8764522
OpenAlexW4205925420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.